← Back
Petmed Express
PETS · listed on Nasdaq · worth $25.58 million
$1.19
+0.00% on Nov 2
No insider bought or sold Petmed Express stock on the market in the last year.
◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
13.3M shares
61% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
No insider bought or sold Petmed Express stock on the market in the last year. The reports below are share awards and other paperwork.
Big investors
People and funds that reported owning 5% or more of Petmed Express, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateSilvercape Investments12.1%Jun 29
All reports
Every insider trade and SEC report we hold for Petmed Express.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Aug 14, 2025BoughtSilvercape InvestmentsAug 14, 2025 · Traded Aug 13, 2025 · 10% owner+3.9%101,000 @ $3.17$320.2K
Aug 4, 2025BoughtSilvercape InvestmentsAug 4, 2025 · Traded Aug 1, 2025 · 10% owner+4.8%118,200 @ $3.21$379.4K
Jul 22, 2025BoughtNina Capital HoldingsJul 22, 2025 · Traded Jul 21, 2025 · 10% owner+1.0%25,000 @ $3.50$87.4K
Jul 21, 2025BoughtSilvercape InvestmentsJul 21, 2025 · Traded Jul 18, 2025 · 10% owner+0.7%17,565 @ $3.23$56.7K
Jul 18, 2025BoughtSilvercape InvestmentsJul 18, 2025 · Traded Jul 17, 2025 · 10% owner+1.4%31,701 @ $3.15$99.9K
3 more with Pro →Analysts, earnings and news
Analysts' price target
$1.40 average
1 analyst
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
0 of 4 quarters above
Q2 '26−$0.28 a share−$0.40
Q1 '26−$0.19 a share−$0.01
Q4 '25−$0.50 a share−$0.44
Q3 '25−$0.41 a share−$0.45